ArticleOpen forum infectious diseases2025
Increasing Birth-Dose Hepatitis B Vaccination in Nigeria: Qualitative Analysis of Data From a Crowdsourcing Open Call.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
Background: Despite World Health Organization and Nigerian recommendations for hepatitis B birth-dose (HepB-BD) vaccination, only one-third of Nigerian newborns receive timely HepB-BD vaccination, This study identified facilitators to increasing HepB-BD vaccination based on data from a crowdsourcing open call in Nigeria. Methods: Our team conducted an open call across Nigeria for teams to submit ideas on how to increase HepB-BD vaccination. Independent judges evaluated the submissions based on predefined criteria. We analyzed textual data from the top 29 entries using iterative coding and thematic analysis within a socioecological model to identify priority facilitators. Results: The open call received 362 total submissions, and 58.5% (215/362) of submissions were from women. Analysis of the top 29 submissions revealed 6 priority facilitators for increasing HepB-BD vaccination: (1) engage religious and healthcare leaders to educate pregnant women; (2) strengthen national policies for vaccination support and tracking; (3) counter misconceptions to promote attitude and behavior changes; (4) utilize rural infrastructure like town halls and radio programs to disseminate information; (5) translate educational materials into local languages like pidgin; and (6) organize financial or social incentives. Conclusions: Our crowdsourcing open call identified key facilitators and strategies for increasing HepB-BD vaccination among Nigerian newborns. The findings from this study can inform HepB-BD initiatives in Nigeria and other low- and middle-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.